Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Intangibles (2018 - 2024)

PAVmed has reported Intangibles over the past 4 years, most recently at $877000.0 for Q3 2024.

  • For Q3 2024, Intangibles changed N/A year-over-year to $877000.0; the TTM value through Sep 2024 reached $877000.0, changed N/A, while the annual FY2023 figure was $1.4 million, 58.66% down from the prior year.
  • Intangibles for Q3 2024 was $877000.0 at PAVmed, down from $947000.0 in the prior quarter.
  • Over five years, Intangibles peaked at $7.6 million in Q1 2022 and troughed at $47000.0 in Q3 2021.
  • A 4-year average of $2.8 million and a median of $2.2 million in 2021 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: surged 8304.26% in 2022 and later plummeted 80.43% in 2024.
  • Year by year, Intangibles stood at $2.2 million in 2021, then surged by 58.39% to $3.4 million in 2022, then plummeted by 58.66% to $1.4 million in 2023, then tumbled by 38.41% to $877000.0 in 2024.
  • Business Quant data shows Intangibles for PAVM at $877000.0 in Q3 2024, $947000.0 in Q2 2024, and $1.1 million in Q1 2024.